Cathal Friel, CEO of Open Orphan #ORPH discusses their new 3-year contract with a tier one German pharmaceutical company and progress on their merger with Hvivo #HVO
Home » Open Orphan (ORPH) » Open Orphan #ORPH CEO Cathal Friel discusses contract wins & hVIVO #HVO merger on the Vox Markets podcast